Abstract
The thyroid is a highly specialized endocrine gland devoted to the production of thyroid hormones through several enzymatic steps. The thyroid hormones are iodinated derivatives of tyrosine and effect their functions through the interaction with nuclear receptor found in almost every human tissue. The thyroid mostly produces thyroxine, or tetraiodothyronine (T4), an inactive prohormone. The T4 production by the thyroid gland is almost only regulated by the pituitary hormone thyrotropin (TSH), which is in turn also almost only regulated by T4 levels, resulting in one of the tightest feedback loops in the endocrine system. T4 is transformed into the only active hormone, triiodothyronine (T3), by a set of enzymes in peripheral tissues, the deiodinases. T3 regulates the transcription of large number of genes, with significant effects in almost every tissue. Several conditions can cause insufficient T4 production, with variable effects on many tissues, organs, and systems. Besides by history and physical exam, thyroid underactivity is accurately diagnosed by reliable measurements of serum TSH, T4, and T3. Since the defect in thyroid underactivity is lack of T4 production, treatment consists in the administration of supplemental T4, a safe, inexpensive, and effective product. Areas of uncertainty remain. The bioavailability of oral T4 is less than perfect in most and utterly insufficient in a few cases. Processes regulating the local production of T3, which could have significant impact on physiology and disease, remain poorly understood at the clinical level, due to the difficult access to thyroid hormone levels in individual tissues.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
The thyroid hormones are unique among the hormones in that their structure contains a micronutrient in short supply, iodine. The dependence on iodine, a scarce element in many regions of the world, exposes the thyroid gland to dietary iodine deficiency. In addition, the synthesis of thyroid hormone requires a number of complex enzymatic processes, including the concentration of iodine in the follicular cell; the organification of iodine into the side chain of tyrosine; the coupling of tyrosines to form T4; the incorporation of T4 in the primary structure of a large storage protein, thyroglobulin; and the secretion of stored thyroid hormone. This array of unique proteins such as thyroglobulin and thyroid peroxidase, and the TSH receptor, makes the thyroid particular susceptible to faulty immune tolerance, so that the thyroid is the most common target of organ-specific autoimmunity. As a consequence thyroid underactivity, or hypothyroidism, is one of the most common endocrine dysfunctions encountered in clinical practice. In addition, these complex processes expose the thyroid gland to surprisingly rare congenital defects affecting T4 production.
Causes of Thyroid Underactivity
In the past, severe iodine deficiency has represented a major cause of hypothyroidism worldwide, especially in the pediatric age. Nowadays severe iodine deficiency has become rare [1]. In moderately iodine-deficient regions, hypothyroidism is now more common than in iodine-sufficient regions. In both moderately iodine-deficient and iodine-sufficient regions, spontaneous hypothyroidism is almost always caused by thyroid autoimmunity, in the form of chronic lymphocytic, or Hashimoto’s, thyroiditis (HT). In HT, autoimmune T and B cell lymphocytes reactive to thyroid antigens invade the gland and progressively exhaust it. This results in variable and variably progressive compromise of the gland’s ability to synthesize thyroid hormone [2]. Iatrogenic thyroid underactivity is the second most common cause, resulting from total or partial thyroidectomy or from radioactive iodine treatment for a number of conditions, such as toxic multinodular goiter or Graves’ disease. Interesting, but very rare cause of hypothyroidism includes inherited errors in the biosynthesis of thyroid hormone. Congenital hypothyroidism is mostly due to developmental or metabolic errors. Rarely, hypothyroidism may result from pituitary dysfunction, leading to insufficient TSH production.
Diagnosis
The diagnosis of hypothyroidism is based on the measurement of serum TSH. Since any minimal change in thyroid hormone results in logarithmic changes in TSH, and since there are no other significant physiologic determinants of the TSH level, a TSH measurement is considered the most sensitive test for hypothyroidism. A normal TSH level rules out hypothyroidism, with the rare exception of central hypothyroidism, in which the TSH may be normal or low. Central hypothyroidism is diagnosed by the finding of low thyroxine in a subject with low or normal TSH. The actual thyroid hormone level may be useful in assessing the severity of hypothyroidism. In subclinical hypothyroidism, the TSH is midly elevated, but thyroid hormones are in the normal range, while overt hypothyroidism is defined by abnormally low thyroid hormones. This distinction is somewhat artificial, as there is clearly a continuum of thyroid dysfunction, but it has been adopted in many published studies.
Clinical Manifestations
Symptoms of hypothyroidism depend on the severity of the dysfunction, but there is also individual variation in the response. Patients with subclinical hypothyroidism are typically asymptomatic, but several studies show a number of subtle cardiovascular, metabolic, and neurologic adverse changes, mostly in subjects younger than 65 and in those with TSH >10 mcIU/mL [3]. Whether subclinical hypothyroidism has significant untoward effects in the elderly remains unclear. With overt hypothyroidism more prominent symptoms are often observed, affecting virtually all organ systems (Table 9.1).
Treatment of Hypothyroidism
In the absence of symptoms, treatment of subclinical hypothyroidism is recommended only in the younger group of patients after confirmation of the diagnosis with a repeat test a few weeks after the first [3]. There is general agreement that overt hypothyroidism should always be treated [4]. While T3 is the only active thyroid hormone in all target tissues, the hormonal defect in hypothyroidism is lack of T4 production from the thyroid gland. Effective treatment is therefore achieved with the oral administration of T4 (levothyroxine), to be later deiodinated to T3 in peripheral tissues. This is indeed the most effective form of hormone replacement in medicine. Owing to its long half-life, levothyroxine achieves stable T4 levels and restores euthyroidism. Restoration of euthyroidism is verified by the achievement of normal serum TSH levels. There are remaining areas of uncertainty. In spite of biochemical euthyroidism, many patients continue to experience non-specific symptoms such as fatigue, weight gain, and subjective cognitive abnormalities. Thyroid hormone replacement with a mixture of T4 and T3 has been tried and generally proven ineffective in this regard, so that the practice is typically not recommended in most cases [5]. The bioavailability of oral levothyroxine is imperfect at best and a relatively common cause of inconsistent euthyroidism during treatment. Interaction with other drugs in the gastrointestinal tract is the most common cause [6]. Novel soft gel and liquid preparations of levothyroxine have recently been developed, but their role remains to be defined by well-designed studies [7].
References
Zimmermann MB, Boelaert K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol. 2015;3(4):286–95.
Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med. 1996;335(2):99–107.
Biondi B, Cappola AR, Cooper DS. Subclinical hypothyroidism: a review. JAMA. 2019;322(2):153–60.
Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, et al. Clinical practice guidelines for hypothyroidism in adults: co-sponsored by American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18:988–1028.
Hennessey JV, Espaillat R. Current evidence for the treatment of hypothyroidism with levothyroxine/levotriiodothyronine combination therapy versus levothyroxine monotherapy. Int J Clin Pract. 2018;72(2):e13062.
Barbesino G. Drugs affecting thyroid function. Thyroid. 2010;20(7):763–70.
Nagy EV, Perros P, Papini E, Katko M, Hegedus L. New formulations of levothyroxine in the treatment of hypothyroidism: trick or treat? Thyroid. 2021;31(2):193–201.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Barbesino, G. (2022). Introduction. In: Davies, T.F. (eds) A Case-Based Guide to Clinical Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-030-84367-0_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-84367-0_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-84366-3
Online ISBN: 978-3-030-84367-0
eBook Packages: MedicineMedicine (R0)